1. Executive Summary
2. Research Methodology
3. Sleep Apnea
3.1 Overview
3.2 Classification
3.2.1 Obstructive Sleep Apnea (OSA)
3.2.2 Mixed Sleep Apnea
3.2.3 Central Sleep Apnea (CSA)
3.3 Diagnosis & Treatment
3.3.1 Continuous Positive Airway Pressure (CPAP)
3.3.2 Other Airway Pressure Devices
3.3.3 Surgical Option
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Type
4.2.2 Market Share by Product
4.2.3 Market Share by Region
5. Market Segmentation
5.1 Therapeutic Devices
5.1.1 Continuous Positive Airway Pressure (CPAP)
5.1.2 Oral Appliances
5.2 Diagnostic Devices
5.2.1 Polysomnography Devices (PSG)
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.1.2.1 Market Sizing (Actual & Forecasted)
6.1.2.2 Market Share by Products
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Germany
6.2.2.1 Market Sizing (Actual & Forecasted)
6.2.2.2 Market Share by Type of Device
6.2.3 The UK
6.2.3.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
6.3.2 China
6.3.2.1 Market Sizing (Actual & Forecasted)
6.3.3 India
6.3.3.1 Market Sizing (Actual & Forecasted)
6.4 Latin America
6.4.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trends & Developments
7.1.1 Home Testing for Sleep Apnea
7.1.2 Advent of Auto-titrating CPAP
7.3 Growth Drivers
7.3.1 Prevalence of Sleep Apnea
7.3.2 Higher Incidence of Lifestyle-Related Chronic Diseases
7.3.3 Increasing Obesity
7.3.4 Rising Demand in Emerging Markets
7.3.5 Increasing Geriatric Population
7.4 Challenges
7.4.1 High Cost of Device
7.4.2 Stringent Regulatory Norms
8. Competitive Landscape
8.1 Comparative Analysis
8.2 Market Share Analysis
8.2.1 Global
8.2.2 Regional
9. Company Profiles
9.1 ResMed Inc.
9.2 Fisher & Paykel Healthcare
9.3 Philips Respironics
9.4 CareFusion